Alzheimer's Disease

Journal of Molecular and Genetic medicine is a peer review journal for Alzheimer's disease that allows free access (Open Access) to its contents and permits authors to contribute final accepted version of the articles. The journal will cover technical and clinical studies related to health, ethical and social issues in field of Alzheimer's disease and related. Articles with clinical interest and implications will be given preference. Journal of Molecular and Genetic medicine intends to impart the enhanced clinical profits for human wellbeing from the trial and translational research performed utilizing molecular tools. Areas that are secured incorporate, yet are not restricted to, tumor science, immunology, neuroscience, cardiovascular disease, heredity and genomics, gene therapy and stem cells and regenerative medicine. OMICS Group Journals encourages original and well researched articles for publication. With the help of a strong 25, 000 experts as editorial board members and reviewers, OMICS Group journals uphold the standard review process. We have more than 50,000+ editorial board members and more than 15 million readers. It has more than 700+ peer-reviewed journals and organizes more than 3000+ International Scientific Conferences.